This is a historical report — it no longer reflects this drug's current status. Current status: Active Shortage. View this drug's full profile page →

Permanently Discontinued

TEVA-NYSTATIN

TEVA CANADA LIMITED

View this drug's full profile page →

This is a national manufacturer shortage report. It does not confirm whether the product is unavailable at your local pharmacy — call ahead or ask your pharmacist.

Quick answers

Is there a shortage of TEVA-NYSTATIN in Canada?

Yes. TEVA-NYSTATIN 100000UNIT has an active shortage reported to Health Canada (last updated June 4, 2026).

Why is TEVA-NYSTATIN not available?

The reason the manufacturer reported: Disruption of the manufacture of the drug.

When will TEVA-NYSTATIN be available again?

No estimated resolution date has been reported yet. Follow this page to get an email as soon as the status changes.

Can I still get this?Possibly — same-ingredient product records found

StatusPermanently Discontinued

Same-ingredient products on file1 product

Affected strength100000UNIT

Report last updated2018-10-12

Checked by MedShort2026-11-12

Other Products Containing the Same Active Ingredient

These are other Health Canada-approved human drug products containing the same active ingredient, not currently reported in shortage. Strength, dosage form, and route can still differ — ask your pharmacist whether any of these are appropriate for you. This isn't a guarantee of current stock.

Closest Matches

JAMP-NYSTATIN ORAL SUSPENSION USP

JAMP PHARMA CORPORATION

100000UNIT · DIN 02433443

Same strengthSame dosage formSame routeNo current shortage

Compare these two →

What this means

Does this mean I need to switch medications right away?

Not necessarily right away, but this product will not be returning to the market.

What should I do?

Talk to your pharmacist or prescriber about your options well before your current supply runs out.

Have you checked a pharmacy recently?

No community reports yet — be the first to share what you found.

Community reports are not verified by a pharmacy and may reflect a small sample size. This is not a guarantee of current stock.

DIN

02194201

Strength

100000UNIT

Dosage Form

SUSPENSION

Route

ORAL

Active Ingredient

NYSTATIN

Tier

Unrated

Last Updated

2018-10-12

Reason for Shortage

Business reasons

Source

View original report on healthproductshortages.ca ↗

Past Reports for This Drug

TEVA-NYSTATIN has 3 shortage/discontinuation reports on file — this is one of them.

2026-06-04

Active Shortage

Disruption of the manufacture of the drug.

2018-10-12

Permanently Discontinued

Business reasons

Other Products from TEVA CANADA LIMITED

Other Health Canada-approved products made by the same manufacturer — not necessarily related to this shortage, and not necessarily in shortage themselves.

ACETAMINOPHEN WITH CODEINE - CAPLET

DIN 02143933

DIN 00834319

3.5MG · DIN 02438399

0.5MG · DIN 02301407

100MG · DIN 02420155

200MG · DIN 02420163